SCHEMBL10301867

SCHEMBL10301867

CCOc1ccc(C2CCC(/C=C/c3ccc(C)cc3F)CC2)c(F)c1F

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 4/20 0.35
SLC6A4 P31645 4/20 0.35
HTR1A P08908 2/20 0.35
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
TSHR P16473 2/20 0.33
NFE2L2 Q16236 1/20 0.33
HRH1 P35367 1/20 0.32
MRGPRX1 Q96LB2 1/20 0.32
PTGDR2 Q9Y5Y4 1/20 0.32
KDM1A O60341 2/20 0.32
POLB P06746 2/20 0.32
MAPT P10636 2/20 0.32
ALDH1A1 P00352 1/20 0.32
SLC6A3 Q01959 3/20 0.32
KDM4E B2RXH2 1/20 0.32
PPARD Q03181 1/20 0.31
MAOB P27338 1/20 0.31
TUBB1 Q9H4B7 1/20 0.31
MAOA P21397 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10301873 0.92 SCN9A (0.35) SLC6A2SLC6A4HTR1ANFE2L2PTGDR2
SCHEMBL10301872 0.91 THRB (0.36) SLC6A2SLC6A4HTR1ANFE2L2MAPT
SCHEMBL10301874 0.90 THRB (0.35) SLC6A2SLC6A4HTR1AMAPTALDH1A1
SCHEMBL10301876 0.90 THRB (0.35) SLC6A2SLC6A4HTR1AMAPTALDH1A1
SCHEMBL10301862 0.88 HTR6 (0.32) KDM1AMAOBTUBB1MAOAHTR6
SCHEMBL10301880 0.88 HTR1A (0.34) SLC6A2SLC6A4HTR1AL3MBTL1
SCHEMBL10301879 0.88 HTR1A (0.34) SLC6A2SLC6A4HTR1A
SCHEMBL1242653 0.87 KDM1A (0.32) KDM1A
SCHEMBL1242657 0.87 KDM1A (0.32) KDM1A
SCHEMBL10302975 0.87 CYP1A1 (0.40) NFE2L2PTGDR2TUBB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8216489-B2 Three-ring liquid crystal compound having lateral fluorine, liquid crystal composition, and liquid crystal display device JNC CORPORATION (JP) 2012-07-10 US disclosed
US-20110037024-A1 THREE-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE CHISSO CORPORATION (JP) 2011-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110037024-A1 THREE-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE LEF1, LAS1L, L3MBTL3 SLC6A2 3969/4885SLC6A4 3574/4885HTR1A 591/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.